 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 23, 2021 |
| Title |
RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways.
|
| |
|
| Overall design |
The SU8686 cells were treated with 20 μM SGC0946 or DMSO for 72 hr (triplicate)
|
| |
|
| Contributor(s) |
Liu Z, Liu Y, Qian L, Jiang S, Gai X, Ye S, Chen Y, Wang X, Zhai L, Xu J, Pu C, Li J, He F, Huang M, Tan M |
| Citation(s) |
34375582 |
| Submission date |
Oct 18, 2019 |
| Last update date |
Sep 22, 2021 |
| Contact name |
Zhiwei Liu |
| E-mail(s) |
lzw150@outlook.com
|
| Organization name |
Chinese Academy of Sciences
|
| Street address |
Zuchongzhi Road 555
|
| City |
Shanghai |
| ZIP/Postal code |
201203 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA578266 |
| SRA |
SRP226165 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE139070_transcript.fpkm.matrix.annot.xls.gz |
21.4 Mb |
(ftp)(http) |
XLS |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...